Latest Articles

Publication Date
'It took three miscarriages to diagnose my debilitating condition - now I need £4k op' - Yahoo News UK

'It took three miscarriages to diagnose my debilitating condition - now I need £4k op' Yahoo News UK

Published: Nov. 3, 2025, 11:58 a.m.
Misleading Lesions in Gynecological Malignancies: A Case Report of Desmoid Tumor During Pregnancy and a Narrative Review of the Literature.

Background: Desmoid tumors (DTs) are rare, locally aggressive soft-tissue neoplasms that often affect women of reproductive age. Pregnancy and prior abdominal surgery or trauma have been associated with tumor development …

Published: Nov. 3, 2025, midnight
Potency of oral gonadotropin-releasing hormone antagonist as endometriosis-associated pain novel treatments: An updated meta-analysis of randomized controlled trials.

Elagolix, Linzagolix, and Relugolix, as oral gonadotropin-releasing hormone antagonists, have emerged as promising treatments for endometriosis-associated pain.

Published: Nov. 1, 2025, midnight
MicroRNAs Regulating Oxidative Stress in Human Fertility: A Narrative Review of Mechanistic Insights and Clinical Potential.

Human infertility represents a multifaceted condition, with oxidative stress (OS) and microRNAs (miRNAs) emerging as key contributors to its pathophysiology. This comprehensive review explores the complex interplay between reactive oxygen …

Published: Oct. 31, 2025, midnight
Neuroendocrine-Immune Axis in Endometriosis: A Review on How the Nervous System Goes Beyond Pain Perception.

Endometriosis (EMS) is an estrogen-dependent disorder that affects about 10% of reproductive-age women. EMS affects female neuroendocrine and reproductive functions, greatly compromising female reproductive health and quality of life. However, …

Published: Oct. 31, 2025, midnight
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - MSN

Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment MSN

Published: Oct. 30, 2025, 11:45 a.m.
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - MSN

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment MSN

Published: Oct. 30, 2025, 10:54 a.m.
'Doctors misdiagnosed me with cancer — they apologized after my hysterectomy' - MSN

'Doctors misdiagnosed me with cancer — they apologized after my hysterectomy' MSN

Published: Oct. 30, 2025, 2:56 a.m.
Clinicopathological Diagnosis and Prognosis of Endometrioid Borderline Ovarian Tumors: Dual Case Reports and Literature Review.

Endometrioid borderline ovarian tumor (EBOT) is rare and frequently misdiagnosed. This study aims to investigate the clinicopathological features, immunohistochemical characteristics, differential diagnosis, therapeutic approaches and disease prognosis, thereby establishing a …

Published: Oct. 30, 2025, midnight
Integrative microbiome-metabolomics identifies Pseudomonas as a potential pathogenic factor in endometriosis.

Endometriosis (EMS) is a chronic disease characterized by unclear etiology, influenced by various genetic and environmental factors, with no definitive biomarkers available for early screening. Recent studies suggest that the …

Published: Oct. 30, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!